LKB1 attenuates the transport activity of GLUT1 by regulating the alternative splicing of PKM1/PKM2 in cervical cancer Authors: Mingzhe Wu, Yaoxing Guo, Jinghua Yang, Enhua Wang, Hong-Tao Xu, Guang-Ping Wu, Huanyu Zhao Published: 2026 ABSTRACT ObjectiveLiver kinase B1 (LKB1) is a tumor suppressor that negatively regulates glucose transporter 1 (GLUT1) in Peutz-Jeghers Syndrome, but its mechanism in cervical cancer is unclear.MethodsLKB1 expression was detected in cervical cancer specimens by real-time polymerase chain reaction. The double directional genetic manipulation, Nuclear and Cytoplasmic Protein separation technique and immunofluorescence were performed to detect the regulatory relationships among LKB1, pyruvate kinase isozyme type M2 (PKM2), hypoxia-inducible factor 1α (HIF-1α), and GLUT1 in cervical cancer cells, and Plasma Membrane and Cytoplasmic Protein separation technique and glucose uptake assay were used to verify the transport activity of GLUT1. LKB1-overexpression and -knockdown cervical cancer cell lines were generated in vitro.ResultsLKB1 messenger RNA level was lower in cervical cancer tissues than in matched paracancerous tissues. LKB1 was highly expressed in the cytoplasm of C33A, but was absent in its nucleus. And LKB1 was absent in SiHa. LKB1 regulated the alternative splicing of PKM1/PKM2. LKB1 overexpression significantly downregulated the PKM2pS37 expression in the nucleus and cytoplasm, the HIF-1α expression in the nucleus, and the GLUT1 expression in the plasma membrane. PKM2 knockdown reduced the nuclear accumulation of HIF-1α. Moreover, PKM2/HIF-1α knockdown reduced the glucose uptake of GLUT1. LKB1 negatively regulated the interaction between PKM2 and HIF-1α via AMPK signaling so as to inhibit the malignant phenotype of cervical cancer cells.ConclusionLKB1 attenuates GLUT1 transport activity by inhibiting the PKM2/HIF-1α pathway, supporting the important roles of PKM2 and HIF-1α in the pathogenesis of cervical cancer. INTRODUCTION Liver kinase B1 (LKB1) known as serine/threonine kinase 11 (STK11), is a tumor suppressor gene. It was first identified in patients with Peutz-Jeghers syndrome (PJS). It is also an important genetic basis for cancer susceptibility [12]. LKB1 participates in cell cycle and apoptosis [34]. LKB1 is inversely proportional to the expressions of hTERT and hTERC, the main components of telomerase, and LKB1 can negatively regulate their expressions [56]. It has been reported that LKB1 and pyruvate kinase isozyme type M2 (PKM2) have synergistic effect on the growth of tumor cells [7] and that the decrease in PKM1/PKM2 ratio is a key factor in tumor progression and glycolysis [8], but it is currently unclear whether LKB1 can regulate the alternative splicing of PKM1/PKM2. PKM2 is a rate-limiting glycolysis terminal enzyme, which plays a major role in the aerobic glycolysis of cancer cells. It catalyzes the conversion of phosphoenolpyruvate to pyruvate and releases energy, thus providing selective growth advantages for cancer cells [9]. PKM2 overexpression promotes the proliferation, invasion, and epithelial stromal transformation of cervical cancer cell [10]. The protein kinase function of PKM2 has attracted much attention recently, the activation of growth factor receptors and T cell receptors blocks tetramerization of PKM2 pyruvate kinase activity [1112]. Interestingly, PKM2 promotes the accumulation of hypoxia-inducible factor 1α (HIF-1α) through nuclear factor-κB (NF-κB) activation in pancreatic cancer cells [13]. PKM2 interacts with HIF-1α and activates the HIF-1α-dependent Warburg effect for aerobic glycolysis [14]. HIF-1α activation results in the enhancement of glycolysis [15], stimulates cancer cell proliferation, apoptosis resistance, migration, and invasion in different cancer cells [16], and binds to the promoter region of glucose transporter 1 (GLUT1) and simultaneously induces the messenger RNA (mRNA) and protein expressions of GLUT1 and the translocation of GLUT1 to plasma membranes in adipocytes [17]. LKB1 negatively regulates the GLUT1 expression and the glucose utilization in the patients with PJS [18]. In cervical cancer, the molecular mechanism by which LKB1 affects the transport activity of GLUT1 remains to be elucidated. The cancer cells use the Warburg effect to consume more glucose to obtain energy by aerobic glycolysis [19]. In this process, the transport activity of glucose transporter GLUT1 plays a key role. GLUT1 is potentially relevant as a diagnostic tool and glucose metabolism as a therapeutic target in cervical cancer [20]. The key role that GLUT1 plays in the Warburg effect is not to increase the GLUT1 expression in the cytoplasm, but to increase the glucose transport activity. Therefore, exploring the molecular mechanism that LKB1 attenuates the transport activity of GLUT1 by regulating PKM2 and HIF-1α may provide a potential target for the treatment of cervical cancer. This study aims to investigate whether the attenuation of GLUT1 transport activity by LKB1 in cervical cancer cells is related to the inhibition of signal pathway of PKM2/HIF-1α. Particularly, we need to explore the activation status of PKM2, the accumulation of HIF-1α in the nucleus, and the transport activity of GLUT1 in cervical cancer cells. MATERIALS AND METHODS 1. Bioinformatics analysis The first step of the research involved a gene enrichment analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG) as the pathway gene set. Gene Set Enrichment Analysis (GSEA) is a computational method to identify all enriched biological pathways found to be associated with LKB1 gene expression. It was performed in the high-expression and the low-expression groups compared with the median level of LKB1 expression respectively. For each analysis, gene set permutation was performed 1,000 times. Gene sets with a normal p-value less than 5% and false discovery rate less than 25% were considered statistically significant. Further confirmed the variable splicing protein downstream of LKB1 by searching the STRING database (https://cn.string-db.org/). The interaction partners of STK11 were identified using the STRING database under the following conditions: Database – STRING (version 11.5); Query protein – STK11; Organism – Homo sapiens; and Key parameters – Default settings were used, encompassing all active interaction sources and a medium confidence score (0.400). 2. Cell culture Human cervical carcinoma cell lines SiHa (HPV16-positive) and C33A (HPV-negative) were purchased from the Pricella® (Pricella Biotechnology Co., Ltd., Wuhan, China), and were cultured in Hyclone Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum (FBS; CellMax, Beijing, China). The cells were cultured in a humidified incubator at 37°C with 5% CO2. 3. Cervical cancer specimens We collected 30 fresh matched sets of cervical cancer tissues and adjacent non-cancerous tissues, which were immediately stored at −70°C for mRNA extraction. These specimens were obtained during surgical resection. From 2022 to 2023, these patients underwent surgery at the First Hospital of China Medical University, and none received radiotherapy or chemotherapy before resection. This retrospective study was conducted in accordance with the guidelines of the Institutional Review Board of the First Hospital of China Medical University (No. 2021-80). The patient consent was waived due to retrospective nature of the study. Tumor specimens were obtained during surgical resection. 4. Reagents and transfection The plasmids for pcDNA3-LKB1-His and pcDNA3-His were gifts from Professor Xin Hou (College of Life Sciences, Inner Mongolia University, Hohhot, China). The small interfering RNAs (siRNAs) against LKB1, PKM2, and HIF-1α were purchased from RIBOBIO (Guangzhou, China). Scrambled siRNA was used as a non-specific siRNA control. The sequences of above siRNAs were shown in Table S1. Three distinct siRNAs targeting different sequences of each gene were designed and synthesized. Following transfection, the knockdown efficiency of each siRNA was quantitatively evaluated using real-time PCR analysis (Fig. S1). The single most effective siRNA, which demonstrated the highest knockdown efficiency for each respective gene, was then selected for all subsequent functional experiments. AMPK inhibitor GSK690693 (50 nM) was purchased from Beyotime Institute of Biotechnology (Shanghai, China). The transfection was performed as described in a previous study [21]. 5. Real-time polymerase chain reaction (PCR) analysis The PrimeScript™ RT Reagent Kit (TaKaRa, Dalian, China) was used to perform real-time PCR. The experiments were conducted as previously described [5]. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was the internal control. The sequences of primers are listed in Table S2. 6. Western blotting Western blotting analysis was performed as described previously [5]. Protein bands were visualized by using electrochemiluminescence substrate (Pierce) and detected by using BioImaging Systems (DNR, Jerusalem, Israel). GAPDH, β-actin, Histone or ATPase protein levels were used as the control group to calculate relative protein levels. The following primary antibodies were used: LKB1 (Cat. No. bs-3948R, 1:800; Bioss, Beijing, China), PKM1 or PKM2 (Cat. No. #7067 or 4053, 1:1,000; Cell Signaling Technology, Danvers, MA, USA), PKM2pS37 (Ser37, Cat. No. #310080, 1:500; ZEN-BIOSCIENCE, Chengdu, China), HIF-1α (Cat. No. #3716, 1:1,000; Cell Signaling Technology), GLUT1 (Cat. No. WL01163, 1:500; Wanleibio, Shenyang, China), phosphorylated AMP-activated protein kinase (p-AMPK, Cat. No. ab314032, 1:1,000; Abcam Co., Ltd., Cambridge, UK), AMPK (Cat. No. ab214425, 1:1,000; Abcam Co., Ltd.), GAPDH (Cat. No. #5174, 1:1,000; Cell Signaling Technology), β-actin (Cat. No. P30002, 1:1,000; Abmart Shanghai Co., Ltd., Shanghai, China), Histone H3 (Cat. No. #ab1791, 1:1,000; Abcam Co., Ltd.), and Sodium Potassium ATPase antibody (EP1845Y, Cat. No. #ab76020, 1:100,000; Abcam Co., Ltd.). GAPDH, Histone, and ATPase were used as the internal controls of cytoplasm, nucleus, and plasma membrane, respectively. 7. Nuclear and Cytoplasmic Protein combined with Plasma Membrane and Cytoplasmic Protein separation technique According to the manufacturer’s instructions, nuclear separation was carried out by using Nuclear and Cytoplasmic Protein Extraction Kit (Cat. No. P0028; Beyotime Institute of Biotechnology, Shanghai, China) and Plasma Membrane and Cytoplasmic Protein Extraction Kit (Cat. No. P0033; Beyotime Institute of Biotechnology). Before using plasma membrane protein extraction reagent A, nuclear protein extraction reagent and plasma membrane protein extraction reagent B, adding phenylmethanesulfonyl fluoride (PMSF) to make the final concentration of PMSF 1 mM. Then adding protein extraction reagents containing PMSF to the cell precipitation and ice bath after shaking. Five times of centrifugation were followed. The protein concentration of the extracted protein sample was determined by bicinchoninic acid protein concentration determination kit (Cat. No. P0010S; Beyotime Institute of Biotechnology), and all operations were carried out in strict accordance with the instructions. 8. Immunofluorescence assay Cells were cultured at 90% confluence and were seeded into a 24-well culture plate. Following gene transfection or siRNA interference, the cells were cultured for 24 hours. Subsequently, 500 µL cell suspension (5×104 cells/ml) was added at a 24-well culture plate. A 15-mm round cover glass slide was pre-inserted into the bottom of each 24-well late (Wuxi NEST Biotechnology Co., Ltd., Wuxi, China) and cells were cultured for an additional 24 hours to form a confluent monolayer. Cells were subsequently washed with ice-cold phosphate-buffered saline (PBS) and fixed with methanol. Permeability treatment was performed with PBS containing 0.2% Triton X-100 and the coverslips were incubated with anti-HIF-1α (Cat. No. #3716, 1:200; Cell Signaling Technology) at 4°C overnight. Two hours after the incubation with CoraLite488-conjugated pure goat anti-rabbit IgG (H+L) secondary antibody (Cat. No. SA00013-2; Proteintech Group, Inc., Wuhan, China), the coverslips were mounted in Prolong Gold antifade reagent with 4′,6′-diamidino-2-phenylindole (Beyotime Institute of Biotechnology). Images were obtained using a fluorescent microscopy (BX-51; Olympus Corporation, Tokyo, Japan). 9. Glucose uptake assay Cells (2–5×104 cells/well) were seeded one day before starting the assay. After 12 hours, the regular culture medium (10% FBS) was removed, and cells were either transfected with siPKM2 or siHIF-1α in 400 µL culture medium supplemented with 0.5% FBS, and incubated at 37°C with 5% CO2 for 3 hours. Then, 4 mL of the 2-N-([7-nitro-2,1,3-benzoxadiazol-4-yl] amino)-D-glucose (2-NBDG) uorescent glucose analogue (BioVision, Milpitas, CA, USA) was added to each sample and incubated at 37°C with 5% CO2 for 30 minutes. After the incubation, cells from the plate were kept on ice and washed once with 1 mL ice-cold 1× analysis buffer. The image analysis under confocal microscopy (IX3-FP; Olympus Corporation, Tokyo, Japan) was used to observe the fluorescence localization of GLUT1. The fluorescence intensity reflected by the relative level of 2-NBDG was measured using the ImageJ software (National Institutes of Health, Bethesda, MD, USA). 10. Transwell assay Transwell membranes (8 µm pore polycarbonate membrane) were used in 24-well plates. Matrigel (BD Bioscience, San Jose, CA, USA) was added on the upper surface of the membrane in every well. In the upper chamber, cells (3×105/well) were cultured in 100 µL serum-free medium; in the lower chamber, the medium containing 10% FBS was added. After incubation for 20 hours, cells were stained with hematoxylin (Sigma-Aldrich, St. Louis, MO, USA). Ten fields (400× magnification) of each filter were randomly selected under microscope for counting the number of the invaded cells. 11. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay Cells were plated in 96-well plates (3×103 cells per well) and cultured for 4 days. The survival status of cells was evaluated by MTT assay. The wells were examined with a spectrophotometer at 450 nm using a micro plate reader (Bio-Rad, Hercules, CA, USA). 12. Statistical analysis SPSS 22.0 software (IBM Corp., Armonk, NY, USA) was used for statistical analysis in the present study. Each assay was performed at ≥3 times. The data are expressed as mean ± standard deviation. Student’s t-test was used to evaluate statistical differences between the Transfection group and the NC/Vector group. Visual statistical graphs were generated using GraphPad Prism 8.0 (GraphPad Software Inc., San Diego, CA, USA). Two-way analysis of variance with Dunnett’s and Sidak’s multiple comparison tests was used to determine statistical significance. The p-value <0.05 was considered to indicate a statistically significant difference. RESULTS 1. The screening of LKB1 protein expression in cervical cancer The protein expression levels of LKB1 were detected in both nucleus and cytoplasm of SiHa and C33A cells. Nuclear and Cytoplasmic Protein Extraction analysis demonstrated that the protein expression levels of LKB1 were only high in the cytoplasm of C33A cell, but almost unnoticeable in the both nucleus and cytoplasm of SiHa cell as well as the nucleus of C33A cell (Fig. 1A). LKB1 mRNA level was lower in cervical cancer tissues than in matched paracancerous tissues (Fig. 1B). The LKB1 expression in cervical cancer. (A) Nuclear and Cytoplasmic Protein Extraction analysis. (B) Quantification of LKB1 mRNA level. (C) GSEA analysis. (D) STRING database. (E) Western blotting analysis. Vec: control plasmid, L1: transfection of LKB1 expression plasmid, NC: scrambled siRNA, and siL1: siRNA-LKB1. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GSEA, Gene Set Enrichment Analysis; LKB1, liver kinase B1; mRNA, messenger RNA; ns, no significance; PKM1, pyruvate kinase isozyme type M1; PKM2, pyruvate kinase isozyme type M2; siRNA, small interfering RNA. *p<0.05, **p<0.01, and ***p<0.001. 2. LKB1 regulates the alternative splicing of PKM1/PKM2 The first step of the research involved a gene enrichment analysis using the KECG as the pathway gene set. It was discovered that LKB1 is significantly associated with the spliceosome pathway gene set (Fig. 1C). Further confirmation was obtained by searching the STRING database, which revealed that LKB1 is a functional protein of PKM (Fig. 1D). These findings suggest that LKB1 may regulate the alternative splicing of pyruvate kinase M (PKM) in cervical cancer cells. Finally, this study confirmed that LKB1 overexpression significantly increased the PKM1 expression while decreasing the PKM2 expression in SiHa cells. Conversely, LKB1 knockdown resulted in the opposite outcomes in C33A cells, as shown in Fig. 1E and Fig. S1A. 3. LKB1 significantly downregulated the PKM2pS37 and HIF-1α expressions in the nucleus, and the GLUT1 expression on the plasma membrane in cervical cancer cells To investigate the effect of LKB1 on PKM2, HIF-1α, and GLUT1, Nuclear and Cytoplasmic Protein combined with Plasma Membrane and Cytoplasmic Protein separation technique were performed to detect the expression levels of PKM2, PKM2pS37, HIF-1α, and GLUT1 in the nucleus, plasma membrane, and cytoplasm, respectively. The results showed that LKB1 overexpression significantly downregulated the expression levels of PKM2 and PKM2pS37 in both nucleus and cytoplasm, HIF-1α in the nucleus only (Fig. 2A), and GLUT1 on the plasma membrane only (Fig. 2C) in SiHa cells. On the other hand, LKB1 knockdown received the opposite results in C33A cells, which were presented in Fig. 2B and D. However, the decrease of PKM2 expression was significantly lower than that of PKM2pS37 expression, and the GLUT1 expression in cytoplasm was almost unchanged. The effects of LKB1 on the expressions of PKM2, PKM2pS37, HIF-1α, and GLUT1. (A, B) Nuclear and Cytoplasmic Protein Extraction analysis. (C, D) Plasma Membrane and Cytoplasmic Protein Extraction analysis. Vec: vector, the control plasmid, L1: transfection of LKB1 expression plasmid, NC: a scrambled siRNA, and siL1: siRNA-LKB1. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GLUT1, glucose transporter 1; HIF-1α, hypoxia-inducible factor 1α; LKB1, liver kinase B1; ns, no significance; PKM2, pyruvate kinase isozyme type M2; siRNA, small interfering RNA. *p<0.01, **p<0.01, and ***p<0.001. To investigate the effect of PKM2 on HIF-1α and GLUT1 expressions mediated by LKB1, siRNA-LKB1 and siRNA-PKM2 were co-transfected to C33A cell line. Nuclear and Cytoplasmic Protein combined with Plasma Membrane and Cytoplasmic Protein separation technique were performed to detect the expression levels of PKM2, HIF-1α, and GLUT1 in the nucleus, plasma membrane, and cytoplasm, respectively. The results showed that the LKB1 induced-HIF-1α downregulated expression in the nucleus was restored by PKM2 (Fig. 3A, Fig. S1A and B), as well as LKB1 induced-GLUT1 downregulated expression on the plasma membrane (Fig. 3B, Fig. S1A and B). The effects of LKB1 on the expressions of PKM2, HIF-1α, and GLUT1. (A) Nuclear and Cytoplasmic Protein Extraction analysis. (B) Plasma Membrane and Cytoplasmic Protein Extraction analysis. NC: scrambled siRNA, siL1: siRNA-LKB1, siP2: siRNA-PKM2. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GLUT1, glucose transporter 1; HIF-1α, hypoxia-inducible factor 1α; LKB1, liver kinase B1; ns, no significance; PKM2, pyruvate kinase isozyme type M2; siRNA, small interfering RNA. *p<0.01, **p<0.01. 4. PKM2 knockdown distinctly reduced the nuclear accumulation of HIF-1α To further verify the regulatory role of PKM2 on the nuclear accumulation of HIF-1α, Nuclear and Cytoplasmic Protein separation technology was used to separate the SiHa cells transfected with siRNA-PKM2, and detect the HIF-1α expression in the nucleus by Western blotting. The results showed that siRNA-PKM2 transfection significantly decreased the HIF-1α expression in the nucleus (Fig. 4A, Fig. S1C). Then, we observed the changes of HIF-1α in the nucleus by immunofluorescence. The results indicated that the inhibition of PKM2 distinctly reduced the nuclear accumulation of HIF-1α (Fig. 4B, Fig. S1C). The regulatory effect of PKM2 on HIF-1α expression. (A) Nuclear and Cytoplasmic Protein Extraction analysis. (B) Immunofluorescence analysis. Scale bar, 20 μm. (C) The fluorescence localization of GLUT1. Scale bar, 100 μm. (D) The fluorescence intensity reflected by the relative level of 2-NBDG. NC: scrambled siRNA, siP2: siRNA-PKM2, siH1: siRNA-HIF-1α. 2-NBDG, 2-N-([7-nitro-2,1,3-benzoxadiazol-4-yl] amino)-D-glucose; DAPI, 4′,6′-diamidino-2-phenylindole; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GLUT1, glucose transporter 1; HIF-1α, hypoxia-inducible factor 1α; PKM2, pyruvate kinase isozyme type M2; siRNA, small interfering RNA. *p<0.01, **p<0.01. 5. PKM2 or HIF-1α knockdown reduced the glucose uptake by GLUT1 in cervical cancer cells To further verify the regulatory roles of PKM2 and HIF-1α on the glucose uptake by GLUT1, we applied PKM2 or HIF-1α-specific siRNA to reduce the expressions of PKM2 or HIF-1α in the SiHa cells, and verified the transport activity of GLUT1 through glucose uptake assay. Firstly, we found that the fluorescence localization of GLUT1 was in the plasma membrane. After PKM2 or HIF-1α knockdown, the fluorescence localization of GLUT1 was transformed into cytoplasm in SiHa cells (Fig. 4C, Fig. S1C and D). Then, through the Image J software analysis, we found that the fluorescence intensity of untreated SiHa cells was significantly higher than that of SiHa cells after the knockdown of PKM2 or HIF-1α (Fig. 4D). The results indicated that by inhibiting PKM2 or HIF-1α, both the fluorescence localization and fluorescence intensity were changed, resulting in the significant reduction of glucose uptake of GLUT1 in cervical cancer cells. 6. LKB1 inhibits the proliferation and invasiveness of cervical cancer cell via PKM2 To verify the effect of LKB1 and PKM2 on the biological functions of cervical cancer cell, we co-transfected siRNA-LKB1 and siRNA-PKM2 to C33A cells. LKB1 knockdown promoted the invasiveness and proliferation of C33A cells. Conversely, PKM2 knockdown inhibited the above effects (Fig. 5A-C). In addition, we co-transfected LKB1 expression plasmid and siRNA-PKM2 to SiHa cells. LKB1 overexpression inhibited the invasiveness and proliferation of SiHa cells. And, PKM2 knockdown further inhibited the above effects (Fig. 5D-F). The effects of LKB1 and PKM2 on the biological behavior of cervical cancer cells. Invasiveness of (A, B) C33A and (D, E) SiHa cells, and proliferation of (C) C33A and (F) SiHa cells. NC: scrambled siRNA, siL1: siRNA-LKB1, siP2: siRNA-PKM2, Vec: vector, the control plasmid, L1: transfection of LKB1 expression plasmid. (B) and (E) were the quantification of invasive cells. LKB1, liver kinase B1; PKM2, pyruvate kinase isozyme type M2; siRNA, small interfering RNA. **p<0.01, ***p<0.001. 7. The mechanism by which LKB1 regulates the transport activity of GLUT1 To verify the potential mechanism by which LKB1 regulates the transport activity of GLUT1, we detected the role of the AMPK signaling pathway. Western blotting analysis showed that LKB1 knockdown significantly reduced the expressions of p-AMPK, PKM2, and HIF-1α. GSK690693 treatment (AMPK inhibitor, 50 nM) significantly blocked the inhibitory effect of LKB1 overexpression on the expressions of PKM2 and HIF-1α (Fig. 6A and B). Co-immunoprecipitation assay indicated that LKB1 negatively regulated the interaction between PKM2 and HIF-1α in cervical cancer cell (Fig. 6C). The underlying mechanism of LKB1 action in cervical cancer cell. (A) Western blotting analysis. (B) The quantication of band intensity. GAPDH was an internal control. (C) Co-immunoprecipitation analysis. NC: scrambled siRNA, siL1: siRNA-LKB1, Vec: vector, the control plasmid, L1: transfection of LKB1 expression plasmid, GSK: treatment the cells with GSK690693 (50 nM). GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HIF-1α, hypoxia-inducible factor 1α; IB, immunoblot; IP, immunoprecipitation; LKB1, liver kinase B1; ns, no significance; p-AMPK, phosphorylated AMP-activated protein kinase; PKM2, pyruvate kinase isozyme type M2; siRNA, small interfering RNA. **p<0.01. DISCUSSION The autoimmunity system in human body has the function of spontaneous clearance of HPV carcinogenic proteins [22]. Herein, LKB1 was highly expressed in the cytoplasm of C33A cell with HPV16 (−), but was absent in its nucleus. And, LKB1 was absent in the cytoplasm or nucleus of SiHa cell with HPV16 (+). This result shows that LKB1 and HPV16 each inhibited the expression of the other, and LKB1 also exists in the cytoplasm of normal cervical epithelial cells. When HPV is immersed in the cytoplasm, LKB1 also has a strong inhibitory effect on the E6 and E7 proteins of HPV. If HPV virus is completely cleared in a short time, it is clinically defined as a transient infection of HPV. If HPV continues to infect for a long time, its pathogenicity is greater than LKB1’s anti-cancer ability, and the anti-cancer ability of LKB1 will be completely abolished. With the continuous progress of cervical intraepithelial lesions, cervical cancer will eventually occur. PKM1 and PKM2, which contain coding sequences encoded by exons 9 and 10, respectively, are produced by alternative splicing of the primary PKM RNA transcripts [23]. PKM1 is always expressed in terminally differentiated tissues with constitutive activity, such as muscle and brain, while PKM2 is expressed in tumor cells with synthetic metabolism functions [2425]. PKM2, which is upregulated in most cancer cells, emerges as an attractive target for cancer therapy [9]. In this study, LKB1 overexpression downregulated the PKM2 expression by regulating the alternative splicing of PKM1/PKM2 in cervical cancer cells. LKB1 downregulated hTERC at the mRNA and gene amplification levels by promoting the phosphorylation of Sp1 in lung cancer cells [6]. However, it is not clear whether LKB1 can regulate the expression level and transport activity of GLUT1 in cervical cancer cells. In this study, LKB1 overexpression significantly downregulated the nuclear expression of PKM2pS37 in cervical cancer cells. Conversely, LKB1 knockdown increased the nuclear expression of PKM2pS37. PKM2pS37 located in the nucleus represents the protein kinase activity of PKM2 [26]. This is the carcinogenic activity of PKM2. LKB1 exerts serine kinase activity through phosphorylation of substrate protein. However, LKB1 overexpression decreases the PKM2pS37 expression in this study. We speculate that the regulatory effect of LKB1 on PKM2pS37 is indirect. This detailed regulatory mechanism needs to be further explored in the future. For exploring the regulatory effect of PKM2 on the nuclear accumulation of HIF-1α, the cellular localization expression of HIF-1α was detected by Nuclear and Cytoplasmic Protein separation technique and immunofluorescence in SiHa cell. The result showed that the HIF-1α localization was closely related to the PKM2 regulation. PKM2 knockdown significantly reduced the nuclear expression of HIF-1α but increased its cytoplasmic expression, indicating that PKM2 leads to the nuclear export of HIF-1α. Subsequently, HIF-1α located in the cytoplasm was degraded by 26S proteasome complex [27]. These results suggest that the regulatory effect of PKM2 on HIF-1α is consistent with the effect of p65 on HIF-1α in lung cancer cells [21]. PKM2 regulates HIF-1α in a NF-κB/p65 dependent manner [13]. In addition, this study confirmed that PKM2 increased the cytoplasmic expression of HIF-1α, while LKB1 did not change the cytoplasmic expression of HIF-1α. We speculate that the regulatory effect of PKM2 on HIF-1α is a direct regulatory effect via p65 [13], while the regulatory effect of LKB1 on HIF-1α is an indirect regulatory effect, there may be other regulatory pathways between LKB1 and HIF-1α. This study further explored the regulatory effects of LKB1, PKM2, and HIF-1α on the transport activity of GLUT1 using glucose uptake assays. Firstly, LKB1 downregulated the GLUT1 expression on the plasma membrane, but the cytoplasmic expression of GLUT1 almost did not change. Then, PKM2 and HIF-1α knockdown significantly reduced the glucose uptake of GLUT1 in cervical cancer cells. The simple GLUT1 expression does not represent the transport activity of GLUT1. The cytoplasmic expression of GLUT1 is not directly related to the transport activity, because this part of GLUT1 is not able to play the role of glucose “Porter” due to the cellular localization [28], they do not have transport activity. According to the recent findings of lung cancer cells [29], we further explore the transport activity of GLUT1 using Plasma Membrane and Cytoplasmic Protein separation technique and glucose uptake assay. The results showed that PKM2 or HIF-1α knockdown can significantly reduce the glucose uptake of GLUT1 on the plasma membrane of cervical cancer cells. Bioinformatics analysis indicated that LKB1 positively regulates AMPK activity [30]. Therefore, this study demonstrates that LKB1 exerts its effects by regulating the AMPK signaling pathway. Under AMPK inhibitor GSK690693 treatment, the inhibitory effects of LKB1 on PKM2 and HIF-1α expressions were significantly blocked. The proteomics-based screen identified that PKM2 interacted with the carboxyl terminus of HIF-1α in hypoxic HeLa cells [31]. Herein, co-immunoprecipitation assay indicated that LKB1 negatively regulated the interaction between PKM2 and HIF-1α in cervical cancer cell. PKM2/HIF-1α complex might function to promote GLUT1 membrane localization. By dissociating this complex, LKB1 abolishes its stabilizing effect, leading to the internalization of GLUT1 from the plasma membrane to the cytoplasm. LKB1 attenuates the transport activity of GLUT1 in cervical cancer cells by reducing the nuclear accumulation of HIF-1α due to the alternative splicing of PKM1/PKM2 and the inhibition of the phosphorylation of PKM2 (Ser37). In cervical cancer cell, LKB1 attenuates the transport activity of GLUT1 through inhibiting the signal pathway of PKM2/HIF-1α by regulating the alternative splicing of PKM1/PKM2. The consistent findings in C33A cell line (HPV16-negative) compared to SiHa cell line (HPV16-positive) significantly strengthen our conclusion that the core phenomenon we report is a universal feature in cervical cancer cells, regardless of HPV status. Future studies should include a broader panel of cell lines (including HPV18-positive cell lines like HeLa) to confirm the universality of our model. Our findings provided new evidence to support the important roles of PKM2 and HIF-1α in the pathogenesis of cervical cancer and suggested new therapeutic targets.